Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...

Alphabet’s AI-powered drug discovery company, Isomorphic Labs, is preparing to take its first major leap into the real world.

Isomorphic Labs, the AI-powered drug company spun out of ... as well as modeling how certain proteins might interact with ...

Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

Already, Isomorphic Labs, a spin-off of DeepMind focused on drug discovery, is applying the new AlphaFold model — which it co-designed — to therapeutic drug design, according to a post on the ...

According to tests conducted by Google DeepMind and Isomorphic, AlphaFold 3 can accurately predict 76% of protein interactions with small molecules, compared to 52% for the previous best ...

Google DeepMind’s new AI can model DNA, RNA, and ‘all life’s molecules ... but Isomorphic Labs is working with pharmaceutical partners to use AlphaFold models for drug discovery programs.

Already, Isomorphic Labs, a spin-off of DeepMind focused on drug discovery, is applying the new AlphaFold model -- which it co-designed -- to therapeutic drug design, according to a post on the ...